Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Integrated ResearchASX:IRI -7.81%37 3-Year EBITDA Growth Rate is 7.20% as of Dec. 2025, which is 16% above its 10-year median of 6.20. GuruFocus rates ASX:IRI with a GF Score™ of 37/100 and a GF Value™ of A$0.32 (Fairly Valued). The stock has 4 warning signs investors should review. Among 2,067 Software companies, Integrated Research ranks worse than 58.59% on this metric.
During the past 12 months, Integrated Research's average EBITDA Per Share Growth Rate was -41.00% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 7.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Integrated Research was 44.50% per year. The lowest was -36.80% per year. And the median was 6.20% per year.
Integrated Research (ASX:IRI) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Integrated Research 3-Year EBITDA Growth Rate Related Terms
ASX:IRI vs QH, SHOP, UBER: 3-Year EBITDA Growth Rate Comparison
For the Software - Application subindustry, Integrated Research's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Integrated Research 3-Year EBITDA Growth Rate vs Software Industry
For the Software industry and Technology sector, Integrated Research's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Integrated Research's 3-Year EBITDA Growth Rate falls into.
Integrated Research 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 7.20% mean?
Integrated Research (ASX:IRI) has a 3-Year EBITDA Growth Rate of 7.20% as of Dec. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Integrated Research and its competitors. This is 16% above median its historical median of 6.20. According to the industry distribution chart, Integrated Research ranks #1211 out of 2067 companies in the Software industry, placing it in the top 58.6%.
Is Integrated Research's 3-Year EBITDA Growth Rate too high?
Integrated Research's current 3-Year EBITDA Growth Rate of 7.20% is 16% above median its 10-year median of 6.20. The Software industry median 3-Year EBITDA Growth Rate is 12.30. Integrated Research's value of 7.20% is 41.5% below this industry median. Based on the distribution chart, Integrated Research ranks #1211 out of 2067 companies in the Software industry, which is below the industry midpoint. Overall, Integrated Research has a GF Score™ of 37/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Integrated Research's 3-Year EBITDA Growth Rate compare to QH and SHOP?
According to the Software industry distribution chart, Integrated Research ranks #1211 out of 2067 companies for 3-Year EBITDA Growth Rate. This places Integrated Research in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 12.30. Integrated Research's value of 7.20% is 41.5% below this benchmark. While the company's 10-year median is 6.20 vs. the industry median of 12.30, Integrated Research has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Software company?
The median 3-Year EBITDA Growth Rate among Software companies is 12.30, based on 2,067 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Integrated Research's current 3-Year EBITDA Growth Rate of 7.20% is 41.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Integrated Research and its competitors. For the Software industry, the median 3-Year EBITDA Growth Rate is 12.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Integrated Research's current 3-Year EBITDA Growth Rate is 7.20%, which is 16% above median its own 10-year median of 6.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integrated Research stock overvalued right now?
Based on GuruFocus' analysis, Integrated Research (ASX:IRI) is currently considered Fairly Valued. The stock's GF Value™ is A$0.32, compared to a current price of A$0.30 — trading 7.8% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 7.20%, which is 16% above median its 10-year median of 6.20 and 41.5% below the Software industry median of 12.30. Integrated Research's overall GF Score™ is 37/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Integrated Research (ASX:IRI), the current 3-Year EBITDA Growth Rate is 7.20% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Integrated Research (ASX:IRI) Overvalued in 2026?
Based on GuruFocus' analysis, Integrated Research stock appears to be undervalued.
The current stock price of A$0.30 is trading 7.8% below its estimated GF Value™ of A$0.32.
GuruFocus considers Integrated Research to be Fairly Valued.
Key valuation signals for ASX:IRI:
3-Year EBITDA Growth Rate: 7.20% (16% above median its 10-year median of 6.20)
GF Value™: A$0.32 vs. price of A$0.30 (7.8% below fair value)
Industry Position: 41.5% below the Software median (#1211 of 2067)
No single metric tells the full story. See the ASX:IRI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Integrated Research Ltd is engaged in the design, development, implementation, and sale of systems and applications management computer software for business-critical computing, Unified Communication networks, and Payment networks. Its Prognosis platform is an integrated suite of monitoring and management software, designed to give its clients, an operational insight into and optimize the operation of their HP NonStop, distributed system servers, Unified Communications (UC), Payment environments, and the business applications that run on these platforms. The company's geographic segments include Asia Pacific, Americas, and Europe. It generates revenue from licence fees, maintenance fees, subscription fees, testing solution services, and professional services.
37GF Score
Get the complete analysis for ASX:IRI
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:IRI has been successfully added to your 
